These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 33089105)
41. Moderate Exercise Suppresses NF-κB Signaling and Activates the SIRT1-AMPK-PGC1α Axis to Attenuate Muscle Loss in Diabetic Liu HW; Chang SJ Front Physiol; 2018; 9():636. PubMed ID: 29896118 [TBL] [Abstract][Full Text] [Related]
42. ETA as a novel Kv2.1 inhibitor ameliorates β-cell dysfunction and hyperglycaemia. Zhou T; Du M; Zhao T; Quan L; Zhu Z; Chen J Clin Exp Pharmacol Physiol; 2018 Dec; 45(12):1257-1264. PubMed ID: 30003581 [TBL] [Abstract][Full Text] [Related]
43. Adenosine Monophosphate-Activated Protein Kinase Abates Hyperglycaemia-Induced Neuronal Injury in Experimental Models of Diabetic Neuropathy: Effects on Mitochondrial Biogenesis, Autophagy and Neuroinflammation. Yerra VG; Areti A; Kumar A Mol Neurobiol; 2017 Apr; 54(3):2301-2312. PubMed ID: 26957299 [TBL] [Abstract][Full Text] [Related]
44. Small-molecule GSK-3 inhibitor rescued apoptosis and neurodegeneration in anesthetics-injured dorsal root ganglion neurons. Yu T; Lin W Biomed Pharmacother; 2016 Dec; 84():395-402. PubMed ID: 27668540 [TBL] [Abstract][Full Text] [Related]
45. RNA-Binding Proteins HuB, HuC, and HuD are Distinctly Regulated in Dorsal Root Ganglia Neurons from STZ-Sensitive Compared to STZ-Resistant Diabetic Mice. Mustăciosu CC; Banciu A; Rusu CM; Banciu DD; Savu D; Radu M; Radu BM Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013625 [TBL] [Abstract][Full Text] [Related]
46. GDNF promotes neurite outgrowth and upregulates galectin-1 through the RET/PI3K signaling in cultured adult rat dorsal root ganglion neurons. Takaku S; Yanagisawa H; Watabe K; Horie H; Kadoya T; Sakumi K; Nakabeppu Y; Poirier F; Sango K Neurochem Int; 2013 Feb; 62(3):330-9. PubMed ID: 23340048 [TBL] [Abstract][Full Text] [Related]
47. miRNA-155 silencing reduces sciatic nerve injury in diabetic peripheral neuropathy. Chen J; Li C; Liu W; Yan B; Hu X; Yang F J Mol Endocrinol; 2019 Oct; 63(3):227-238. PubMed ID: 31404910 [TBL] [Abstract][Full Text] [Related]
48. Role of mitochondria in diabetic peripheral neuropathy: Influencing the NAD Chandrasekaran K; Anjaneyulu M; Choi J; Kumar P; Salimian M; Ho CY; Russell JW Int Rev Neurobiol; 2019; 145():177-209. PubMed ID: 31208524 [TBL] [Abstract][Full Text] [Related]
50. Combination of active components of Xiexin decoction ameliorates renal fibrosis through the inhibition of NF-κB and TGF-β1/Smad pathways in db/db diabetic mice. Wu JS; Shi R; Lu X; Ma YM; Cheng NN PLoS One; 2015; 10(3):e0122661. PubMed ID: 25803610 [TBL] [Abstract][Full Text] [Related]
51. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes. Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340 [TBL] [Abstract][Full Text] [Related]
52. Modulation of Diabetes-Induced Oxidative Stress, Apoptosis, and Ca Kahya MC; Nazıroğlu M; Övey İS Mol Neurobiol; 2017 Apr; 54(3):2345-2360. PubMed ID: 26957303 [TBL] [Abstract][Full Text] [Related]
53. Sigma 1 receptor mediated HMGB1 expression in spinal cord is involved in the development of diabetic neuropathic pain. Wang X; Feng C; Qiao Y; Zhao X Neurosci Lett; 2018 Mar; 668():164-168. PubMed ID: 29421543 [TBL] [Abstract][Full Text] [Related]
54. Microarray analyses of lncRNAs and mRNAs expression profiling associated with diabetic peripheral neuropathy in rats. Guo G; Ren S; Kang Y; Liu Y; Duscher D; Machens HG; Chen Z J Cell Biochem; 2019 Sep; 120(9):15347-15359. PubMed ID: 31025414 [TBL] [Abstract][Full Text] [Related]
55. Partial blockade of Kv2.1 channel potentiates GLP-1's insulinotropic effects in islets and reduces its dose required for improving glucose tolerance in type 2 diabetic male mice. Sukma Rita R; Dezaki K; Kurashina T; Kakei M; Yada T Endocrinology; 2015 Jan; 156(1):114-23. PubMed ID: 25337656 [TBL] [Abstract][Full Text] [Related]
56. Metabolomic signature of type 1 diabetes-induced sensory loss and nerve damage in diabetic neuropathy. Rojas DR; Kuner R; Agarwal N J Mol Med (Berl); 2019 Jun; 97(6):845-854. PubMed ID: 30949723 [TBL] [Abstract][Full Text] [Related]
57. Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons. Ma J; Pan P; Anyika M; Blagg BS; Dobrowsky RT ACS Chem Neurosci; 2015 Sep; 6(9):1637-48. PubMed ID: 26161583 [TBL] [Abstract][Full Text] [Related]
58. Angiopoietin-1/Tie2 signaling pathway contributes to the therapeutic effect of thymosin β4 on diabetic peripheral neuropathy. Wang L; Chopp M; Szalad A; Lu X; Lu M; Zhang T; Zhang ZG Neurosci Res; 2019 Oct; 147():1-8. PubMed ID: 30326249 [TBL] [Abstract][Full Text] [Related]
59. Retracted: Lidocaine Ameliorates Diabetic Peripheral Neuropathy in Streptozotocin-Induced Diabetic Rats through Modulating the c-Jun Signaling Pathway. Imaging CMM Contrast Media Mol Imaging; 2023; 2023():9823696. PubMed ID: 37547643 [TBL] [Abstract][Full Text] [Related]
60. SP6616 as a Kv2.1 inhibitor efficiently ameliorates peripheral neuropathy in diabetic mice. Zhu X; Chen Y; Xu X; Xu X; Lu Y; Huang X; Zhou J; Hu L; Wang J; Shen X EBioMedicine; 2020 Nov; 61():103061. PubMed ID: 33096484 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]